½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1542413

¼¼°èÀÇ ½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Cardiac Rhythm Management Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 119 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 224¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â °ÅÀÇ 405¾ï 8,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2024-2032³â Á¶»ç ±â°£ µ¿¾È 6.82%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÀå¹Úµ¿°ü¸®(CRM) ±â±â´Â ºÎÁ¤¸ÆÀ» ¸ð´ÏÅ͸µ, Áø´Ü ¹× Ä¡·áÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡´Â ½É¹ÚÁ¶À²±â, À̽ÄÇü Á¦¼¼µ¿±â(ICD), ½ÉÀåÀ絿±âÈ­¿ä¹ý(CRT) ±â±â°¡ Æ÷ÇԵ˴ϴÙ. ½É¹ÚÁ¶À²±â´Â ½ÉÀå ¸®µëÀÌ ´À¸®°Å³ª ºÒ±ÔÄ¢ÇÑ È¯ÀÚÀÇ ½ÉÀå ¹Úµ¿À» Á¶ÀýÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ICD´Â »ý¸íÀ» À§ÇùÇÏ´Â ºÎÁ¤¸ÆÀ» Ä¡·áÇϱâ À§ÇØ Ãæ°ÝÀ» ÁÖ¸ç, CRT´Â ½ÉºÎÀü ȯÀÚÀÇ ½ÉÀå ÆßÇÁ ±â´ÉÀ» °³¼±ÇÏ°í, CRM Àåºñ´Â ´Ù¾çÇÑ ½ÉÀå ÁúȯÀ» °ü¸®ÇÏ°í, ȯÀÚ °á°ú¸¦ °³¼±Çϸç, ½ÉÀå ¸®µë Àå¾Ö¸¦ °¡Áø »ç¶÷µéÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀåÀº ½ÉÀå ºÎÁ¤¸Æ°ú ½ÉºÎÀü À¯º´·üÀÇ Áõ°¡·Î ÀÎÇØ °í±Þ °ü¸® ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÑ ½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀåÀÌ ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­ ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº CRM ±â±âÀÇ ±â¼úÀû ¹ßÀüÀº ȯÀÚ Ä¡·á¿Í ÆíÀǼºÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â »õ·Î¿î ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù. °í·ÉÈ­ Àα¸ÀÇ Áõ°¡¿Í ½ÉÀå °Ç°­¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡µµ ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù. ¹èÅ͸® ¼ö¸í Çâ»ó, µ¥ÀÌÅÍ ºÐ¼® ±â´É µî CRM ±â±â ±â¼úÀÇ Çõ½ÅÀº ½ÃÀå È®´ë¿Í ȯÀÚ ¿¹ÈÄ °³¼±¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ±â±â ºñ¿ë°ú ±ÔÁ¦ À̽´´Â ½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆľÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ½ÉÀå¹Úµ¿°ü¸® ±â±â ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå¹Úµ¿°ü¸® ±â±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ ÇØ´ç Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °í°´°ú ÇâÈÄ ±âȸ¸¦ ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

Á¦Ç°º°

  • ÆäÀ̽º¸ÞÀÌÄ¿(À̽ÄÇü, ü¿ÜÇü)
  • Á¦¼¼µ¿±â(À̽ÄÇü Á¦¼¼µ¿±â(ICD)(S-ICD, T-ICD), ü¿ÜÇü Á¦¼¼µ¿±â(¼öµ¿Çü ü¿ÜÇü Á¦¼¼µ¿±â, ÀÚµ¿Çü ü¿ÜÇü Á¦¼¼µ¿±â, ÀåÂøÇü Á¦¼¼µ¿±â))
  • ½ÉÀåÀ絿±âÈ­¿ä¹ý(CRT)(CRT-Á¦¼¼µ¿±â, CRT-ÆäÀ̽º¸ÞÀÌÄ¿)

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ÀúÈñ¿¡°Ô ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ½ÉÀå¹Úµ¿°ü¸® ±â±â - »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆà ä³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆà ä³Î ¹ßÀü µ¿Çâ

Á¦5Àå ½ÉÀå¹Úµ¿°ü¸® ±â±â ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • Á¦Ç°º° °ú°Å ¹× ¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ÆäÀ̽º¸ÞÀÌÄ¿(À̽ÄÇü, ü¿Ü½Ä)
  • Á¦¼¼µ¿±â(À̽ÄÇü Á¦¼¼µ¿±â(ICD)(S-ICD, T-ICD), ü¿Ü½Ä Á¦¼¼µ¿±â(¼öµ¿½Ä ü¿Ü½Ä Á¦¼¼µ¿±â, ÀÚµ¿½Ä ü¿Ü½Ä Á¦¼¼µ¿±â, ÀåÂøÇü Á¦¼¼µ¿±â))
  • ½ÉÀåÀ絿±âÈ­Ä¡·á(CRT)(CRT-Á¦¼¼µ¿±â, CRT-ÆäÀ̽º¸ÞÀÌÄ¿)

Á¦6Àå ½ÉÀå¹Úµ¿°ü¸® ±â±â ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹ÌÀÇ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ ºÎ¹®º°
    • À¯·´ ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîƼ³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå ½ÉÀå¹Úµ¿°ü¸® ±â±â ±â¾÷ °æÀï »óȲ

  • ½ÉÀå¹Úµ¿°ü¸® ±â±â ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇÕÀÇ
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦8Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Physio-Control Inc.
  • Medtronic Plc
  • Abbott
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips N.V.
  • BIOTRONIK
  • Progetti Srl
  • Zoll Medical Corporation
  • LivaNova Plc
ksm 24.09.13

The global demand for Cardiac Rhythm Management Devices Market is presumed to reach the market size of nearly USD 40.58 Billion by 2032 from USD 22.41 Billion in 2023 with a CAGR of 6.82% under the study period 2024-2032.

Cardiac rhythm management (CRM) devices monitor, diagnose, and treat irregular heart rhythms or arrhythmias. These devices include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Pacemakers help regulate heartbeats in patients with slow or irregular heart rhythms, while ICDs provide shocks to correct life-threatening arrhythmias. CRT devices improve the heart's pumping efficiency in patients with heart failure. CRM devices are crucial for managing various cardiac conditions, improving patient outcomes, and enhancing the quality of life for individuals with heart rhythm disorders.

MARKET DYNAMICS

The cardiac rhythm management devices market is driven by the increasing prevalence of cardiac arrhythmias and heart failure, necessitating advanced management solutions. Technological advancements in CRM devices, such as miniaturized and remote monitoring systems, create new opportunities for improved patient care and convenience. The expanding aging population and rising awareness about heart health further fuel market growth. Opportunities also arise from expanding healthcare infrastructure and increasing access to advanced medical technologies in emerging markets. Innovations in CRM device technologies, including enhanced battery life and data analytics capabilities, contribute to market expansion and improved patient outcomes. However, high device costs and regulatory challenges may restrain the growth of the cardiac rhythm management devices market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Rhythm Management Devices. The growth and trends of Cardiac Rhythm Management Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Rhythm Management Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Pacemakers (Implantable, External)
  • Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator))
  • Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Rhythm Management Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Rhythm Management Devices market include Physio-Control Inc., Medtronic Plc, Abbott, Boston Scientific Corporation, Schiller, Koninklijke Philips N.V., BIOTRONIK, Progetti Srl, Zoll Medical Corporation, LivaNova Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARDIAC RHYTHM MANAGEMENT DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Pacemakers (Implantable, External) Historic and Forecast Sales By Regions
  • 5.4. Defibrillators (Implantable Cardioverter Defibrillators (ICD) (S-ICD, T-ICD), External Defibrillator (Manual External Defibrillator, Automatic External Defibrillator, Wearable Cardioverter Defibrillator)) Historic and Forecast Sales By Regions
  • 5.5. Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemakers) Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CARDIAC RHYTHM MANAGEMENT DEVICES COMPANIES

  • 7.1. Cardiac Rhythm Management Devices Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Physio-Control Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Medtronic Plc
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Abbott
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. Boston Scientific Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Schiller
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. Koninklijke Philips N.V.
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. BIOTRONIK
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments
  • 8.10. Progetti Srl
    • 8.10.1 Company Overview
    • 8.10.2 Company Revenue
    • 8.10.3 Products
    • 8.10.4 Recent Developments
  • 8.11. Zoll Medical Corporation
    • 8.11.1 Company Overview
    • 8.11.2 Company Revenue
    • 8.11.3 Products
    • 8.11.4 Recent Developments
  • 8.12. LivaNova Plc
    • 8.12.1 Company Overview
    • 8.12.2 Company Revenue
    • 8.12.3 Products
    • 8.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦